Nanobodies: Next Generation of Cancer Diagnostics and Therapeutics
نویسندگان
چکیده
منابع مشابه
Nucleic Acid Aptamer-Guided Cancer Therapeutics and Diagnostics: the Next Generation of Cancer Medicine
Conventional anticancer therapies, such as chemo- and/or radio-therapy are often unable to completely eradicate cancers due to abnormal tumor microenvironment, as well as increased drug/radiation resistance. More effective therapeutic strategies for overcoming these obstacles are urgently in demand. Aptamers, as chemical antibodies that bind to targets with high affinity and specificity, are a ...
متن کاملRNA-guided diagnostics and therapeutics for next-generation individualized nanomedicine.
The absence of reliable quantitative laboratory tests for measurements of microRNAs and other classes of small noncoding RNAs in archived, formalin- fixed, paraffin-embedded human samples with sufficient specificity and sensitivity has significantly limited the development of clinically relevant noncoding RNA–based diagnostic and therapeutic applications. A report by Renwick et al. in this issu...
متن کاملNext-Generation Therapeutics for IBD
Various novel drugs have recently been evaluated in clinical trials showing promising effects in patients with inflammatory bowel disease (IBD). Here, we summarize the recent literature in the area of emerging therapies in the field of IBD, with specific focus on anti-integrin antibodies, such as vedolizumab (anti-α4β7) and etrolizumab (anti-rhuMAb β7), and the Janus kinase (JAK) inhibitor tofa...
متن کاملNext-generation microfluidic point-of-care diagnostics.
Microfluidics or lab-on-a-chip (LOC) diagnostic devices have the potential to provide fast, laboratory-quality results to expedite clinical decisions at various point-ofcare (POC) settings, including outpatient clinics, emergency rooms, and intensive care units (1 ). Unfortunately, these technologies remain out of reach in the developing world, where lack of access to quality diagnoses contribu...
متن کاملNext generation therapeutics for Alzheimer's disease
To date, no truly effective therapy has been developed for Alzheimer's disease or mild cognitive impairment. In searching for new approaches that may succeed where previous ones have failed, it may be instructive to consider the successful therapeutic developments for other chronic illnesses such as cancer and human immunodeficiency virus.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Frontiers in Oncology
سال: 2020
ISSN: 2234-943X
DOI: 10.3389/fonc.2020.01182